Healthcare -
Biotechnology - NASDAQ - US
$ 1.05
2.94 %
$ 57.8 M
Market Cap
-0.59
P/E
PRLD - CASH & EQUIVALENTS
Cash & Equivalents PRLD - Prelude Therapeutics Incorporated
25.3 M
LAST VALUE
-10.86%
2 YEAR CAGR
10.15%
5 YEAR CAGR
0.00%
10 YEAR CAGR